Cargando…

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry

BACKGROUND: Pulmonary endarterectomy (PEA), pulmonary arterial hypertension (PAH) therapy and balloon pulmonary angioplasty (BPA) are currently accepted therapies for chronic thromboembolic pulmonary hypertension (CTEPH). This international CTEPH Registry identifies clinical characteristics of patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guth, Stefan, D'Armini, Andrea M., Delcroix, Marion, Nakayama, Kazuhiko, Fadel, Elie, Hoole, Stephen P., Jenkins, David P., Kiely, David G., Kim, Nick H., Lang, Irene M., Madani, Michael M., Matsubara, Hiromi, Ogawa, Aiko, Ota-Arakaki, Jaquelina S., Quarck, Rozenn, Sadushi-Kolici, Roela, Simonneau, Gérald, Wiedenroth, Christoph B., Yildizeli, Bedrettin, Mayer, Eckhard, Pepke-Zaba, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365143/ https://www.ncbi.nlm.nih.gov/pubmed/34409094 http://dx.doi.org/10.1183/23120541.00850-2020

Ejemplares similares

Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH
por: Moser, Bernhard, et al.
Publicado: (2014)

Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension
por: Jenkins, David, et al.
Publicado: (2017)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Radiological differences between chronic thromboembolic pulmonary disease (CTEPD) and chronic thromboembolic pulmonary hypertension (CTEPH)
por: Capone, Carmine, et al.
Publicado: (2021)

The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?
por: Quarck, Rozenn, et al.
Publicado: (2023)

Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy
por: Skoro-Sajer, Nika, et al.
Publicado: (2014)

Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension
por: D'Armini, Andrea M.
Publicado: (2015)

Neutrophil extracellular traps and monocyte subsets at the culprit lesion site of myocardial infarction patients
por: Mangold, Andreas, et al.
Publicado: (2019)

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
por: Benza, Raymond L., et al.
Publicado: (2020)

Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021
por: Simonneau, Gérald, et al.
Publicado: (2023)

Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
por: Kriechbaum, Steffen D., et al.
Publicado: (2020)

Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
por: Swinnen, Katleen, et al.
Publicado: (2019)

Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells
por: Tielemans, Birger, et al.
Publicado: (2023)

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil
por: Jansa, Pavel, et al.
Publicado: (2023)

A Comprehensive Assessment of Right Ventricular Function in Chronic Thromboembolic Pulmonary Hypertension
por: Marchetta, Stella, et al.
Publicado: (2022)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

Incremental Experience in In Vitro Primary Culture of Human Pulmonary Arterial Endothelial Cells Harvested from Swan-Ganz Pulmonary Arterial Catheters
por: Tielemans, Birger, et al.
Publicado: (2021)

Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022)

NOVEL CTEPH MIMICKERS IN THE COVID-19 ERA
por: Pietrowicz, Rylie, et al.
Publicado: (2022)

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic
por: Godinas, Laurent, et al.
Publicado: (2021)

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
por: McLaughlin, Vallerie V., et al.
Publicado: (2017)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
por: Kaldararova, Monika, et al.
Publicado: (2022)

Determinants of Severe Nocturnal Hypoxemia in Adults with Chronic Thromboembolic Pulmonary Hypertension and Sleep-Related Breathing Disorders
por: Çınar, Caner, et al.
Publicado: (2023)

Ten-year outcome of chronic thromboembolic pulmonary hypertension patients in a tertiary center
por: Küçükoğlu, Mehmet Serdar, et al.
Publicado: (2020)

Quality of life in patients with chronic thromboembolic pulmonary hypertension
por: Mathai, Stephen C., et al.
Publicado: (2016)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic
por: Jansa, Pavel, et al.
Publicado: (2022)

Chronic Thromboembolic Pulmonary Hypertension Secondary to Thrombophilia and Incidentally Diagnosed Atrial Septal Defect
por: Kilinc, Mehmet, et al.
Publicado: (2020)

Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients
por: Quarck, Rozenn, et al.
Publicado: (2012)

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
por: Boon, Gudula J. A. M., et al.
Publicado: (2020)

Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection
por: Ippoliti, Giovanbattista, et al.
Publicado: (2012)

Leukocytoclastic Vasculitis as a Complication of Recombinant Granulocyte Colony-Stimulating Factor Therapy in a Heart Transplant Patient
por: Ippoliti, Giovanbattista, et al.
Publicado: (2014)

Cytokines trigger disruption of endothelium barrier function and p38 MAP kinase activation in BMPR2-silenced human lung microvascular endothelial cells
por: Tielemans, Birger, et al.
Publicado: (2019)

Pulmonary Endarterectomy in a Patient with Immune Thrombocytopenic Purpura
por: Yıldızeli, Bedrettin, et al.
Publicado: (2015)

The Effect of Perioperative Fluid Management and Operative Modifications on Mortality and Morbidity in Patients Undergoing Pulmonary Endarterectomy
por: Arslan, Akın, et al.
Publicado: (2023)

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH
por: Zhu, Hanqing, et al.
Publicado: (2021)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

Inherited Thrombophilia in Chinese CTEPH Patients: A Rather Common Finding in an Uncommon Condition
por: Kearney, Katherine, et al.
Publicado: (2022)

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
por: Boon, Gudula J. A. M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2vh1ma0mu2l4oa6gs4ns7as655